Products

What will AGI do for Betoxycaine?

This classification denotes an anesthetic agent with the molecular formula C19H32N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 03DB58Y9DO, chemically known as ethanol, 2-(2-(diethylamino)ethoxy)-, 3-amino-4-butoxybenzoate but generally known as betoxycaine, which bears US NIH Compound Identifier 19668. Betoxycaine most often comes in base, q, and hydrochloride forms. European Medicines Agency schedules Betoxycaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05807MIG. The term BETOXYCAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). BETOXYCAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule betoxycaine under HS 29225000 and SITC 51467. As of Q4 2014, BETOXYCAINE remains the US FDA Preferred Term for this commodity. Betoxycaine bears US NLM identifiers UMLS ID C2347003 and NCI Concept Code C72175. SMILES: O(CCN(CC)CC)CCOC(=O)C1CC(N)C(OCCCC)CC1.